These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15986378)

  • 1. Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis.
    Lau DT; Luxon BA; Xiao SY; Beard MR; Lemon SM
    Hepatology; 2005 Aug; 42(2):273-81. PubMed ID: 15986378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C.
    Carotti S; Morini S; Corradini SG; Burza MA; Molinaro A; Carpino G; Merli M; De Santis A; Muda AO; Rossi M; Attili AF; Gaudio E
    Liver Transpl; 2008 Jun; 14(6):806-14. PubMed ID: 18508359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
    Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
    Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
    Bièche I; Asselah T; Laurendeau I; Vidaud D; Degot C; Paradis V; Bedossa P; Valla DC; Marcellin P; Vidaud M
    Virology; 2005 Feb; 332(1):130-44. PubMed ID: 15661146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
    Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
    Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic stellate cells in human schistosomiasis mansoni: a comparative immunohistochemical study with liver cirrhosis.
    Chang D; Ramalho LN; Ramalho FS; Martinelli AL; Zucoloto S
    Acta Trop; 2006 Mar; 97(3):318-23. PubMed ID: 16473318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells.
    Wiercinska E; Wickert L; Denecke B; Said HM; Hamzavi J; Gressner AM; Thorikay M; ten Dijke P; Mertens PR; Breitkopf K; Dooley S
    Hepatology; 2006 May; 43(5):1032-41. PubMed ID: 16628634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
    Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH
    J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFAP expression in the liver as an early marker of stellate cells activation.
    Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study.
    Akpolat N; Yahsi S; Godekmerdan A; Yalniz M; Demirbag K
    Histopathology; 2005 Sep; 47(3):276-80. PubMed ID: 16115228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
    Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
    Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
    Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
    Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.
    Smith MW; Yue ZN; Korth MJ; Do HA; Boix L; Fausto N; Bruix J; Carithers RL; Katze MG
    Hepatology; 2003 Dec; 38(6):1458-67. PubMed ID: 14647057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
    Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y
    Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
    Guido M; Rugge M; Leandro G; Fiel IM; Thung SN
    Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
    Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.